探索人类肠道微生物群的目标与当代抗抑郁药的使用有关
Shih-Kai Kevin Lin1, Hsi-Chung Chen2, Chun-Hsin Chen3
1Department of Public Health, Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei, Taiwan.
Journal of affective disorders
|October 11, 2023
概括
选择性血清素再吸收抑制剂 (SSRI) 和血清素-上腺素再吸收抑制剂 (SNRIs) 改变了抑郁症患者的肠道微生物群多样性和组成. 这些抗抑郁药的使用与特定的细菌种群变化和功能途径有关.
科学领域:
- 微生物组研究的研究.
- 药理学 药理学是指药理学的学科.
- 临床心理学 临床心理学
背景情况:
- 选择性血清素再吸收抑制剂 (SSRI) 和血清素-上腺素再吸收抑制剂 (SNRIs) 广泛用于抑郁症.
- 动物研究表明,抗抑郁药会影响肠道微生物群.
- 关于这种关联的人类研究有限.
研究的目的:
- 调查抗抑郁药使用与人类肠道微生物群组成之间的联系.
- 探索特定细菌种群和功能途径的变化.
主要方法:
- 收集了271名抑郁症患者的抗抑郁药使用,人口统计和临床因素的数据.
- 使用16S rRNA基因测序分析了肠道微生物群.
- 使用MaAsLin2进行组合分析和PICRUSt2进行功能通路预测.
主要成果:
- 抗抑郁药使用者 (SSRI/SNRIs) 显示肠道微生物群多样性减少.
- 七种细菌种群的丰度在抗抑郁药使用者和非使用者之间有显著差异.
- 图里西巴克特的丰富性与SSRI/SNRI使用者的抑郁症严重程度呈现逆相关性.
结论:
- 抗抑郁药的使用,特别是SSRI和SNRIs,与肠道微生物群的改变有关.
- 需要进一步的研究来了解对治疗的临床影响.
- 这些发现可能会为未来针对肠道微生物组的治疗策略提供信息.
相关概念视频
Antidepressant Drugs: Overview
527
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
527
Antidepressant Drugs: MAOIs and Other Agents
256
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
256
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
276
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
276
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
132
Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
132
What is Monogastric Digestion?
71.3K
The human body contains a monogastric digestive system. In a monogastric digestive system, the stomach only contains one chamber in which it digests food. Several other animal species also have monogastric digestive systems, including pigs, horses, dogs, and birds. This chapter, however, focuses on the human digestive system.
71.3K
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
413
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
413


